Sensititre™ EUMDR2F

Confidently perform Antimicrobial Susceptibility Testing (AST) of clinically relevant non-fastidious Gram-negative isolates on a single comprehensive AST panel now containing Aztreonam / Avibactam, Cefepime /Enmetazobactam, and Sulbactam / Durlobactam. Generate clinically impactful data, detect emerging resistance, and help guide timely and accurate antimicrobial therapy by utilising micro-broth dilution - the gold standard¹ phenotypic method for AST.

This convenient panel meets EUCAST breakpoints for a broad range of relevant second line antimicrobials, including Ceftazidime / Avibactam, Colistin, Eravacycline, Imipenem / Relebactam, and Meropenem / Vaborbactam.

Key Features & Product Benefits

•  Deliver consistent turnaround times to support earlier clinical decision-making and targeted therapy, particularly in critical infections such as sepsis.
• Monitor susceptibility among critical Gram-negative isolates with full-range, accurate MIC values for a broad array of clinically relevant antimicrobics.
• For ultimate flexibility automated or manual read options are available with one panel; compatible with all Sensititre™ instrumentation options - designed to be modular in order to meet the unique needs of individual lab space, workload, and budget requirements.
• Eliminate inventory control concerns with extended shelf life (24-months), and room temperature storage.
• Individual packaging allows testing of one sample at a time, with reduced waste.

Order now and transform your testing program with the latest AST panels.

Not all products are available for sale in all territories. Please inquire.